Do you want to read an article? Please log in or register.
A Phase 3, Efficacy and Safety Study of Ertugliflozin Monotherapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Diet and Exercise Alone.
Diabetes - GeneralType 2 DiabetesGlycemic Control